A psychiatrist who believes in the biomedical approach to therapy would probably apex

Review

The biomedical model of mental disorder: a critical analysis of its validity, utility, and effects on psychotherapy research

Brett J Deacon. Clin Psychol Rev. 2013 Nov.

Abstract

The biomedical model posits that mental disorders are brain diseases and emphasizes pharmacological treatment to target presumed biological abnormalities. A biologically-focused approach to science, policy, and practice has dominated the American healthcare system for more than three decades. During this time, the use of psychiatric medications has sharply increased and mental disorders have become commonly regarded as brain diseases caused by chemical imbalances that are corrected with disease-specific drugs. However, despite widespread faith in the potential of neuroscience to revolutionize mental health practice, the biomedical model era has been characterized by a broad lack of clinical innovation and poor mental health outcomes. In addition, the biomedical paradigm has profoundly affected clinical psychology via the adoption of drug trial methodology in psychotherapy research. Although this approach has spurred the development of empirically supported psychological treatments for numerous mental disorders, it has neglected treatment process, inhibited treatment innovation and dissemination, and divided the field along scientist and practitioner lines. The neglected biopsychosocial model represents an appealing alternative to the biomedical approach, and an honest and public dialog about the validity and utility of the biomedical paradigm is urgently needed.

Keywords: Biomedical model; Biopsychosocial model; Chemical imbalance; Disease; Psychotherapy; Treatment.

Copyright © 2013 Elsevier Ltd. All rights reserved.

Similar articles

  • Psychotherapy in psychiatry.

    Gabbard GO. Gabbard GO. Int Rev Psychiatry. 2007 Feb;19(1):5-12. doi: 10.1080/09540260601080813. Int Rev Psychiatry. 2007. PMID: 17365154 Review.

  • The fate of integrated treatment: whatever happened to the biopsychosocial psychiatrist?

    Gabbard GO, Kay J. Gabbard GO, et al. Am J Psychiatry. 2001 Dec;158(12):1956-63. doi: 10.1176/appi.ajp.158.12.1956. Am J Psychiatry. 2001. PMID: 11729008 Review.

  • [Janus-faced therapy: what is common in psychotherapy and pharmacotherapy?].

    Túry F. Túry F. Neuropsychopharmacol Hung. 2004 Mar;6(1):30-5. Neuropsychopharmacol Hung. 2004. PMID: 15125312 Review. Hungarian.

  • Positioning mental health nursing practice within a positive health paradigm.

    Wand T. Wand T. Int J Ment Health Nurs. 2013 Apr;22(2):116-24. doi: 10.1111/j.1447-0349.2012.00848.x. Epub 2012 Oct 1. Int J Ment Health Nurs. 2013. PMID: 23020848 Review.

  • Pharmacotherapy for the soul and psychotherapy for the body.

    Groleger U. Groleger U. Psychiatr Danub. 2007 Sep;19(3):206-8. Psychiatr Danub. 2007. PMID: 17914321

Cited by

  • Bringing Psychology Students Closer to People with Schizophrenia at Pandemic Time: A Study of a Distance Anti-stigma Intervention With In-presence Opportunistic Control Group.

    Magliano L. Magliano L. J Psychosoc Rehabil Ment Health. 2022 Oct 6:1-13. doi: 10.1007/s40737-022-00308-1. Online ahead of print. J Psychosoc Rehabil Ment Health. 2022. PMID: 36217317 Free PMC article.

  • Choosing a health behaviour theory or model for related research projects: a narrative review.

    Beyera GK, O'Brien J, Campbell S. Beyera GK, et al. J Res Nurs. 2022 Aug;27(5):436-446. doi: 10.1177/17449871211051566. Epub 2021 Oct 25. J Res Nurs. 2022. PMID: 36131698

  • Exploring Continuum and Categorical Conceptualisations of Mental Health and Mental Illness on Australian Websites: A Systematic Review and Content Analysis.

    Fernandez DK, Singh S, Deane FP, Vella SA. Fernandez DK, et al. Community Ment Health J. 2022 Aug 22. doi: 10.1007/s10597-022-01005-w. Online ahead of print. Community Ment Health J. 2022. PMID: 35994182

  • An examination of the medicalization and pharmaceuticalization processes of anxiety and depressive disorders in Belgium between 2004 and 2013: how may both disorders be intertwined?

    Kilian VL, de Velde Sarah V. Kilian VL, et al. Arch Public Health. 2022 Aug 15;80(1):191. doi: 10.1186/s13690-022-00943-x. Arch Public Health. 2022. PMID: 35971128 Free PMC article.

  • Measuring Positive Mental Health and Depression in Africa: A Variable-Based and Person-Centred Analysis of the Dual-Continua Model.

    Khumalo IP, Appiah R, Wilson Fadiji A. Khumalo IP, et al. Front Psychol. 2022 Jun 20;13:885278. doi: 10.3389/fpsyg.2022.885278. eCollection 2022. Front Psychol. 2022. PMID: 35795445 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

  • Full Text Sources

    • Elsevier Science
  • Other Literature Sources

    • scite Smart Citations
  • Medical

    • ClinicalTrials.gov
    • MedlinePlus Health Information

What is the biomedical approach in psychology?

The biomedical model posits that mental disorders are brain diseases and emphasizes pharmacological treatment to target presumed biological abnormalities. A biologically-focused approach to science, policy, and practice has dominated the American healthcare system for more than three decades.

What is the biomedical approach to health?

The biomedical model of medicine is the current dominating model of illness used in most Western healthcare settings, and is built from the perception that a state of health is defined purely in the absence of illness.

What does the biomedical model suggest?

A biomedical model is a surrogate for a human being, or a human biologic system, that can be used to understand normal and abnormal function from gene to phenotype and to provide a basis for preventive or therapeutic intervention in human diseases.

What are the advantages of the biomedical model?

The biomedical model has its advantages: It offers explanations of mental ill-health that many people who experience mental health problems find reassuring as it can be the first stage towards recovery.